Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
JCI Insight|October 9, 2019
MiR-16 regulates crosstalk in NF-κB tolerogenic inflammatory signaling between myeloma cells and bone marrow macrophagesJihane Khalife, Jayeeta Ghose, Marianna Martella, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 19, 2019
Multi-institutional evaluation of MVCT guided patient registration and dosimetric precision in total marrow irradiation: A global health initiative by the international consortium of total marrow irradiationDarren Zuro, Stefano Vagge, Sara Broggi, et al.
Transplantation and Cellular Therapy|April 10, 2022
Total Marrow and Lymphoid Irradiation with Post-Transplantation Cyclophosphamide for Patients with AML in RemissionAnthony S Stein, Monzr M Al Malki, Dongyun Yang, et al.
Blood|February 23, 2024
A CD38-directed, single-chain T-cell engager targets leukemia stem cells through IFN-γ-induced CD38 expressionMariam Murtadha, Miso Park, Yinghui Zhu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 24, 2018
Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR ReportFiroozeh Sahebi, Laurent Garderet, Abraham S Kanate, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 18, 2018
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel AgentsFiroozeh Sahebi, Simona Iacobelli, Giulia Sbianchi, et al.
Transplantation and Cellular Therapy|September 20, 2021
Post-Transplantation Cyclophosphamide for Graft-versus- Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison by Donor Type. A Study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow TransplantationFiroozeh Sahebi, Dirk-Jan Eikema, Linda Koster, et al.
The Lancet. Haematology|May 18, 2026
Total marrow and lymphoid irradiation in combination with cyclophosphamide and etoposide before haematopoietic cell transplantation for relapsed or refractory acute leukaemia: a single-centre, open-label, phase 2 trialAnthony Stein, Yan Wang, Monzr M Al Malki, et al.
Blood Advances|October 23, 2020
Identifying CD38+ cells in patients with multiple myeloma: first-in-human imaging using copper-64-labeled daratumumabAmrita Krishnan, Vikram Adhikarla, Erasmus K Poku, et al.
The Journal of Clinical Investigation|April 8, 2025
Identification of CD84 as a potent survival factor in acute myeloid leukemiaYinghui Zhu, Mariam Murtadha, Miaomiao Liu, et al.
Pageof 6